![FDA praise for Biogen's Alzheimer's drug sends it stock soaring by nearly 44 percent - The Boston Globe FDA praise for Biogen's Alzheimer's drug sends it stock soaring by nearly 44 percent - The Boston Globe](https://cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/ESS3KDDDDMI6VAYTDTZL5YDHRM.jpg)
FDA praise for Biogen's Alzheimer's drug sends it stock soaring by nearly 44 percent - The Boston Globe
![1 Year Later: The Biogen 'Superspreader' Conference That Sparked Boston's Coronavirus Outbreak – NBC Boston 1 Year Later: The Biogen 'Superspreader' Conference That Sparked Boston's Coronavirus Outbreak – NBC Boston](https://media.nbcboston.com/2019/09/biogen-1.jpg?quality=85&strip=all&resize=1200%2C675)
1 Year Later: The Biogen 'Superspreader' Conference That Sparked Boston's Coronavirus Outbreak – NBC Boston
![Biogen Alzheimer's drug data spurs five question about the company's future - Boston Business Journal Biogen Alzheimer's drug data spurs five question about the company's future - Boston Business Journal](https://media.bizj.us/view/img/10281191/michelvounatsos2016full1*750xx5760-3246-0-0.jpg)
Biogen Alzheimer's drug data spurs five question about the company's future - Boston Business Journal
![Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for growth' outside of Aduhelm: analyst | Fierce Pharma Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for growth' outside of Aduhelm: analyst | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1632320165/B-roll_CAM_BiogenLogo_BuildingLogoCloseup_img1.jpg/B-roll_CAM_BiogenLogo_BuildingLogoCloseup_img1.jpg?VersionId=fE5mm3PBF0oAgMWsunZt4Hfv1W5Y2JOn)